Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns

Power Life Sciences

Status: Not yet enrolling

Conditions: Merkel Cell Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT06039033

90700326

Details and patient eligibility

About

Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged ≥ 18 years old
• Able to comprehend the investigational nature of the protocol and provide informed consent
• Diagnosis of Merkel cell carcinoma

Exclusion criteria

• No diagnosis of Merkel cell carcinoma confirmed
• Inability to perform regular electronic reporting
• Patient does not understand, sign, and return consent form

Trial design